期刊文献+

同型半胱氨酸和胱抑素C与妊娠糖尿病的关系 被引量:1

Relationship between Homocysteine and Cystatin C and Gestational Diabetes
下载PDF
导出
摘要 目的分析胱抑素C(CysC)、同型半胱氨酸(Hcy)与妊娠糖尿病之间的相关性。方法方便选取该院2014年1月-2019年5月收治的43名正常妊娠孕妇、43例妊娠糖尿病孕妇为研究对象,对两组研究对象血浆CysC、Hcy水平、三酰甘油(TG)以及血糖(GLU)水平进行测定,对比各组测定值的差异性,同时采用Pearson法分析CysC与Hcy之间的相关性。结果妊娠糖尿病组患者GLU、CysC、TG以及Hcy测定值分别为(8.69±1.08)mmol/L、(1.29±0.35)mg/L、(3.09±0.82)mmol/L、(13.78±5.63)μmol/L,均明显高于正常妊娠组的(5.36±0.52)mmol/L、(0.75±0.15)mg/L、(1.66±0.23)mmol/L、(7.12±2.12)μmol/L(t=18.217、19.526、20.122、16.259,P<0.05);妊娠糖尿病患者CysC、Hcy之间为正相关(r=0.918,P<0.05)。结论妊娠糖尿病发病过程中,CysC与Hcy可能发挥了共同作用。 Objective To analyze the correlation between cystatin C(CysC),homocysteine(Hcy)and gestational diabetes.Methods Forty-three normal pregnant women and 43 pregnant women with gestational diabetes who were treated in thehospital from January 2014 to May 2019 were conveniently selected as the research subjects.Plasma CysC,Hcy levels,triacylglycerol(TG)and blood glucose(GLU)level was measured,and the differences between the measured values of each group were compared.At the same time,the correlation between CysC and Hcy was analyzed using the Pearson method.Results The measured values of GLU,CysC,TG and Hcy in patients with gestational diabetes were(8.69±1.08)mmol/L,(1.29±0.35)mg/L,(3.09±0.82)mmol/L,and(13.78±5.63)μmol/L,were significantly higher than(5.36±0.52)mmol/L,(0.75±0.15)mg/L,(1.66±0.23)mmol/L,(7.12±2.12)μmol/L(t=18.217,19.526,20.122,16.259,P<0.05);there was a positive correlation between CysC and Hcy in patients with gestational diabetes(r=0.918,P<0.05).Conclusion CysC and Hcy may play a common role in the pathogenesis of gestational diabetes.
作者 邵玲玲 SHAO Ling-ling(Department of Clinical Laboratory,Rudong County People's Hospital,Rudong,Jiangsu Province,226400 China)
出处 《中外医疗》 2020年第12期40-42,共3页 China & Foreign Medical Treatment
关键词 同型半胱氨酸 胱抑素C 妊娠糖尿病 相关性分析 Homocysteine Cystatin C Gestational diabetes Correlation analysis
  • 相关文献

参考文献10

二级参考文献100

  • 1丁国锋,毛艳华,石斗飞,张洁,刘同刚,张蕾.老年高血压并缺血性脑卒中患者血浆同型半胱氨酸变化的临床意义[J].山东医药,2006,46(1):30-31. 被引量:42
  • 2杨霓芝,刘旭生.糖尿病肾病诊断、辨证分型及疗效评定标准(试行方案)[J].上海中医药杂志,2007,41(7):7-8. 被引量:1188
  • 3Montalescot G,Ankri A,Chadefanx VB,et al.Plasmahomocysteine and the extent of atherosclerosis in patients with coronarydisease[J].Int J Cardiol,1997,(60):295.
  • 4Reece EA,Homke C,Wizntzer A.Metabolic changes in diabetic and mondiabetic subjects durny pregnancy[J].Obstet Gynecol Surv,1994,49(1):64-71.
  • 5Potter K, Hankey GJ, Green DJ, et al. Homocysteine or renal impairment :which is the real cardiovascular risk factor[ J ]. Arterioscler Thromb Vasc Biol, 2008,28 ( 6 ) : 1158-1159.
  • 6Arduino A, Richard J. Homocysteine and cardiovascular risk [ J ]. Am Coil Cardio1,2011,58 ( 10 ) : 1034-1035.
  • 7Hagiiwara S, Kantharidis P,Cooper ME. What are new avenues for renal protection, in addition to RAAS inhi- bition[J]. Curr Hypertens Rep,2012,14(2) .. 100-110.
  • 8Mogensen CE. Early diabetic renal involvement and ne- phropathy in: Alberti KGMM, Krall LP [M]. Amster- dam : ELsevier Science Publishers, 1987 : 306.
  • 9Mogensen CE Schmitz A,Christensen CK. Comparative renal pathophysiology relevant to IDDM and NIDDM patients[J]. Diabetes Metabo Rev, 1988, 4 (5) : 453- 483.
  • 10Emoto M, Kanda H, Shoji T, et al. Impact of insulin re- sistance and nephropathy on homocysteine in type 2 di- abetes[J]. Diabetes Care, 2010,24(3) : 533-538.

共引文献222

同被引文献2

引证文献1

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部